Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...
Vivos Therapeutics shares dropped Thursday after the company said it is offering 1.4 million common shares at $3.15 per share in a registered direct offering. Shares were down 27% to $3.03 in recent ...
Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering ...
Dogecoin (DOGE), the memecoin known for its Shiba Inu mascot, has witnessed a significant increase in network activity. Over ...
Long AXP: strong momentum and upward price targets indicate continued bullish run toward $300 ...
Vivos Therapeutics, Inc. (VVOS), a medical device and technology company, announced on Thursday that it has inked a deal with ...
LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) --. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization ...
Medpage Today on MSN1d
RFK Jr. Helping Trump Pick CDC Chief; Excess COVID Death Lingers; Turmoil at 23andMeKennedy Jr. influence public health under another Trump administration? The known vaccine skeptic says he's helping pick the ...
Vivos Therapeutics shares surged 47.50% to close at $4.13, after hitting an intraday high of $5.95 and a low of $3.02. The ...
On Wednesday, Vivos Therapeutics Inc (VVOS) stock saw a modest uptick, ending the day at $4.13 which represents a slight increase of $1.33 or 47.50% from the prior close of $2.8. The stock opened at ...
What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...
Traders were over the moon as they bought up shares of Vivos Therapeutics Inc. (Nasdaq:VVOS) following the press release, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback